Nanotechnology-Ocular Devices for Glaucoma Treatment: A Literature Review

References

• Quigley H, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90(3):262–67. doi:10.1136/bjo.2005.081224.
   PubMed Web of Science ®Google Scholar
• Quigley HA. Glaucoma. Lancet. 2011;377(9774):1367–77. doi:10.1016/S0140-6736(10)61423-7.
   PubMed Web of Science ®Google Scholar
• Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014;121(11):2081–90. doi:10.1016/j.ophtha.2014.05.013.
   PubMed Web of Science ®Google Scholar
• Flaxman SR, Bourne RRA, Resnikoff S, Ackland P, Braithwaite T, Cicinelli MV, Das A, Jonas JB, Keeffe J, Kempen JH, et al. Global causes of blindness and distance vision impairment 1990–2020: a systematic review and meta-analysis. Lancet Glob Heal. 2017;5(12):e1221–34. doi:10.1016/S2214-109X(17)30393-5.
   PubMed Web of Science ®Google Scholar
• Pita-Thomas DW, Goldberg JL. Nanotechnology and glaucoma: little particles for a big disease. Curr Opin Ophthalmol. 2013;24(2):130–35. doi:10.1097/ICU.0b013e32835cfe92.
   PubMed Web of Science ®Google Scholar
• Delplace V, Payne S, Shoichet M. Delivery strategies for treatment of age-related ocular diseases: from a biological understanding to biomaterial solutions. J Control Release. 2015;219:652–68. doi:10.1016/j.jconrel.2015.09.065.
   PubMed Web of Science ®Google Scholar
• Leske MC, Heijl A, Hussein M, Bengtsson B, Hyman L, Komaroff E. Factors for glaucoma progression and the effect of treatment: the early glaucoma manifest trial. Arch Ophthalmol. 2003;121(1):48–56. doi:10.1001/archopht.121.1.48.
   PubMedGoogle Scholar
• Al-Kinani AA, Zidan G, Elsaid N, Seyfoddin A, Alani AWG, Alany RG. Ophthalmic gels: past, present and future. Adv Drug Deliv Rev. 2018 Feb;15(126):113–26. doi:10.1016/j.addr.2017.12.017.
   Web of Science ®Google Scholar
• Lang JC. Ocular drug delivery conventional ocular formulations. Adv Drug Deliv Rev. 1995;16:39–43.
   Google Scholar
• Le Bourlais C, Acar L, Zia H, Sado PA, Needham T, Leverge R. Ophthalmic drug delivery systems - recent advances. Prog Retin Eye Res. 1998;17(1):33–58. doi:10.1016/S1350-9462(97)00002-5.
   PubMed Web of Science ®Google Scholar
• Gaudana R, Ananthula HK, Parenky A, Mitra AK. Ocular drug delivery. Aaps J. 2010;12(3):348–60. doi:10.1208/s12248-010-9183-3.
   PubMed Web of Science ®Google Scholar
• Razeghinejad MR, Spaeth GL. A history of surgical management of glaucoma.pdf. Optomertry Vis Sci. 2011;88(1):E39–47. doi:10.1097/OPX.0b013e3181fe2226.
   PubMed Web of Science ®Google Scholar
• Roy S, Mermoud A. Deep sclerectomy. Dev Ophthalmol. 2017;59:36–42.
   PubMedGoogle Scholar
• Wagner V, Dullaart A, Bock AK, Zweck A. The emerging nanomedicine landscape. Nat Biotechnol. 2006;24(10):1211–17. doi:10.1038/nbt1006-1211.
   PubMed Web of Science ®Google Scholar
• Leary JF. Nanotechnology: what is it and why is small so big? Can J Ophthalmol/J Can d’Ophtalmologie. 2010;45(5):449–56. doi:10.3129/i10-089.
   PubMed Web of Science ®Google Scholar
• Bhagat N, Grigorian RA, Tutela A, Zarbin MA. Diabetic macular edema: pathogenesis and treatment. Surv Ophthalmol. 2009 Jan-Feb;54(1):1–32. doi:10.1016/j.survophthal.2008.10.001.
   PubMed Web of Science ®Google Scholar
• Kim NJ, Harris A, Gerber A, Tobe LA, Amireskandari A, Huck A, Siesky B. Nanotechnology and glaucoma: a review of the potential implications of glaucoma nanomedicine. Br J Ophthalmol. 2014;98(4):427–31. doi:10.1136/bjophthalmol-2013-304546.
   PubMed Web of Science ®Google Scholar
• Sahoo SK, Labhasetwar V. Nanotech approaches to drug delivery and imaging. Drug Discov Today. 2003;8(24):1112–20. doi:10.1016/S1359-6446(03)02903-9.
   PubMed Web of Science ®Google Scholar
• Sahoo SK, Dilnawaz F, Krishnakumar S. Nanotechnology in ocular drug delivery. Drug Discov Today. 2008;13(3–4):144–51. doi:10.1016/j.drudis.2007.10.021.
   PubMed Web of Science ®Google Scholar
• Staggers N, McCasky T, Brazelton N, Kennedy R. Nanotechnology: the coming revolution and its implications for consumers, clinicians, and informatics. Nurs Outlook. 2008;56(5):268–74. doi:10.1016/j.outlook.2008.02.006.
   PubMed Web of Science ®Google Scholar
• Ferreira Q, Alccer L, Morgado J. Stepwise preparation and characterization of molecular wires made of zinc octaethylporphyrin complexes bridged by 4, 4′-bipyridine on HOPG. Nanotechnology. 2011;22(43):435604. doi:10.1088/0957-4484/22/43/435604.
   PubMed Web of Science ®Google Scholar
• Chow EK, Zhang XQ, Chen M, Lam R, Robinson E, Huang H, Schaffer D, Osawa E, Goga A, Ho D. Nanodiamond therapeutic delivery agents mediate enhanced chemoresistant tumor treatment. Sci Transl Med. 2011;3(73):73ra21–73ra21. doi:10.1126/scitranslmed.3001713.
   PubMed Web of Science ®Google Scholar
• Gagandeep GT, Malik B, Rath G, Goyal AK. Development and characterization of nano-fiber patch for the treatment of glaucoma. Eur J Pharm Sci. 2014;53(1):10–16. doi:10.1016/j.ejps.2013.11.016.
   PubMed Web of Science ®Google Scholar
• Zafar A, Ahmad J, Akhter S, Addo RT. Nanotechnology for transcorneal drug targeting in glaucoma: challenges and progress. In: Richard T. Addo (editor). Ocular drug delivery: advances, challenges and applications. Cham: Springer International Publishing; 2016. p. 75–99.
   Google Scholar
• Chen H, Chen H. Recent developments in ocular drug delivery *. 2015;2330(October). J Drug Target. 2015;23(7–8):597–604.
   Google Scholar
• Hsu KH, Gause S, Chauhan A. Review of ophthalmic drug delivery by contact lenses. J Drug Deliv Sci Technol. 2014;24(2):123–35. doi:10.1016/S1773-2247(14)50021-4.
   Web of Science ®Google Scholar
• Foldvari M. Noninvasive ocular drug delivery: potential transcorneal and other alternative delivery routes for therapeutic molecules in glaucoma. J Glaucoma. 2014;23(8):S80–2. doi:10.1097/IJG.0000000000000122.
   PubMedGoogle Scholar
• Peng CC, Burke MT, Carbia BE, Plummer C, Chauhan A. Extended drug delivery by contact lenses for glaucoma therapy. J Control Release. 2012;162(1):152–58. doi:10.1016/j.jconrel.2012.07.021.
   PubMed Web of Science ®Google Scholar
• González-Chomón C, Concheiro A, Alvarez-Lorenzo C. Soft contact lenses for controlled ocular delivery: 50 years in the making. Ther Deliv. 2013;4(9):1141–61. doi:10.4155/tde.13.81.
   PubMedGoogle Scholar
• Gulsen D, Li CC, Chauhan A. Dispersion of DMPC liposomes in contact lenses for ophthalmic drug delivery. Curr Eye Res. 2005;30(12):1071–80. doi:10.1080/02713680591006282.
   PubMed Web of Science ®Google Scholar
• Jung HJ, Chauhan A. Temperature sensitive contact lenses for triggered ophthalmic drug delivery. Biomaterials. 2012;33(7):2289–300. doi:10.1016/j.biomaterials.2011.10.076.
   PubMed Web of Science ®Google Scholar
• Jung HJ, Abou-Jaoude M, Carbia BE, Plummer C, Chauhan A. Glaucoma therapy by extended release of timolol from nanoparticle loaded silicone-hydrogel contact lenses. J Control Release. 2013;165(1):82–89. doi:10.1016/j.jconrel.2012.10.010.
   PubMed Web of Science ®Google Scholar
• Maulvi FA, Lakdawala DH, Shaikh AA, Desai AR, Choksi HH, Vaidya RJ, Ranch KM, Koli AR, Vyas BA, Shah DO. In vitro and in vivo evaluation of novel implantation technology in hydrogel contact lenses for controlled drug delivery. J Control Release. 2016;226:47–56. doi:10.1016/j.jconrel.2016.02.012.
   PubMed Web of Science ®Google Scholar
• Mehta P, Al-Kinani AA, Haj-Ahmad R, Arshad MS, Chang MW, Alany RG, Ahmad Z. Electrically atomised formulations of Timolol Maleate for direct and on-demand ocular lens coatings. Eur J Pharm Biopharm. 2017;119:170–84. doi:10.1016/j.ejpb.2017.06.016.
   PubMed Web of Science ®Google Scholar
• Mehta P, Al-Kinani A, Arshad MS, Chang M, Alany RG, Ahmad Z. Development and characterisation of electrospun Timolol Maleate-loaded polymeric contact lens coatings containing various permeation enhancers. Int J Pharm. 2017 Oct 30;532(1):408–20. doi:10.1016/j.ijpharm.2017.09.029.
   PubMed Web of Science ®Google Scholar
• Sun J, Lei Y, Dai Z, Liu X, Huang T, Wu J, Xu ZP, Sun X. Sustained release of brimonidine from a new composite drug delivery system for treatment of glaucoma. ACS Appl Mater Interfaces. 2017;9(9):7990–99. doi:10.1021/acsami.6b16509.
   PubMed Web of Science ®Google Scholar
• Kashiwagi K, Ito K, Haniuda H, Ohtsubo S, Takeoka S. Development of latanoprost-loaded biodegradable nanosheet as a new drug delivery system for glaucoma. Investig Ophthalmol Vis Sci. 2013;54(8):5629–37. doi:10.1167/iovs.12-9513.
   PubMed Web of Science ®Google Scholar
• Agban Y, Lian J, Prabakar S, Seyfoddin A, Rupenthal ID. Nanoparticle cross-linked collagen shields for sustained delivery of pilocarpine hydrochloride. Int J Pharm. 2016;501(1–2):96–101. doi:10.1016/j.ijpharm.2016.01.069.
   PubMed Web of Science ®Google Scholar
• Jung HJ, Chauhan A. Extended release of timolol from nanoparticle-loaded fornix insert for glaucoma therapy. J Ocul Pharmacol Ther. 2013;29(2):229–35. doi:10.1089/jop.2012.0114.
   PubMed Web of Science ®Google Scholar
• Franca JR, Foureaux G, Fuscaldi LL, Ribeiro TG, Rodrigues LB, Bravo R, Castilho RO, Yoshida MI, Cardoso VN, Fernandes SO, et al. Bimatoprost-loaded ocular inserts as sustained release drug delivery systems for glaucoma treatment: in vitro and in vivo evaluation. PLoS One. 2014;9(4):1–11. doi:10.1371/journal.pone.0095461.
   Web of Science ®Google Scholar
• Aref AA, Gedde SJ, Budenz DL. Glaucoma drainage implant surgery. Dev Ophthalmol. 2017;59:43–52.
   PubMedGoogle Scholar
• Maleki T, Chitnis G, Hyeong Park J, Cantor LB, Ziaie B. Biodegradable microfabricated plug-filters for glaucoma drainage devices. IEEE Trans Biomed Eng. 2012;59(6):1507–13. doi:10.1109/TBME.2011.2179031.
   PubMed Web of Science ®Google Scholar
• Hong CH, Arosemena A, Zurakowski D, Ayyala RS. Glaucoma drainage devices: A systematic literature review and current controversies. Surv Ophthalmol. 2005;50(1):48–60. doi:10.1016/j.survophthal.2004.10.006.
   PubMed Web of Science ®Google Scholar
• Araújo M, Morgado J, Ferreira Q. Layer-by-layer assembled films for ocular drug delivery. Proc 5th Int Conf Photonics, Opt Laser Technol. 2017;1:BONano,395–401.
   Google Scholar
• Olson JL, Bhandari R, Groman-Lupa S, Velez-Montoya R. A nanopore membrane regulator device for laser modulated flow after glaucoma surgery. Biomed Microdevices. 2015;17(5). doi:10.1007/s10544-015-9985-2.
   Web of Science ®Google Scholar
• Paschalis EI, Chodosh J, Sperling RA, Salvador-Culla B, Dohlman C. A novel implantable glaucoma valve using ferrofluid. PLoS One. 2013;8(6):e67404. doi:10.1371/journal.pone.0067404.
   PubMed Web of Science ®Google Scholar
• Pan T, Brown JD, Ziaie B. An artificial nano-drainage implant (ANDI) for glaucoma treatment. Annu Int Conf IEEE Eng Med Biol - Proc. 2006;1:3174–77.
   Google Scholar
• Harake RS, Ding Y, Brown JD, Pan T. Design, fabrication, and in vitro testing of an anti-biofouling glaucoma micro-shunt. Ann Biomed Eng. 2015;43(10):2394–405. doi:10.1007/s10439-015-1309-4.
   PubMed Web of Science ®Google Scholar
• Alvarado JA, Hollander DA, Juster RP, Lee LC. Ahmed valve implantation with adjunctive mitomycin C and 5-fluorouracil: long-term outcomes. Am J Ophthalmol. 2008;146(2):276–284.e2. doi:10.1016/j.ajo.2008.04.008.
   PubMed Web of Science ®Google Scholar
• Cetinel S, Montemagno C. Nanotechnology applications for glaucoma. Asia-Pacific J Ophthalmol. 2016;5(1):70–78. doi:10.1097/APO.0000000000000171.
   PubMed Web of Science ®Google Scholar
• Costa VP, Azuara-Blanco A, Netland PA, Lesk MR, Arcieri ES. Efficacy and safety of adjunctive mitomycin C during Ahmed glaucoma valve implantation: A prospective randomized clinical trial. Ophthalmology. 2004;111(6):1071–76. doi:10.1016/j.ophtha.2004.04.014.
   PubMed Web of Science ®Google Scholar
• Sahiner N, Kravitz DJ, Qadir R, Blake D, Haque S, John VT, Margo CE, Ayyala RS. Creation of a drug-coated glaucoma drainage device using polymer technology. Arch Ophthalmol. 2009;127(4):448–53. doi:10.1001/archophthalmol.2009.19.
   PubMedGoogle Scholar
• Ponnusamy T, Yu H, John VT, Ayyala RS, Blake DA. A novel antiproliferative drug coating for glaucoma drainage devices. J Glaucoma. 2014;23(8):526–34. doi:10.1097/IJG.0b013e318294869b.
   PubMed Web of Science ®Google Scholar
• Lambert WS, Carlson BJ, van der Ende AE, Shih G, Dobish JN, Calkins DJ, Ritch R, Hood DC. Nanosponge-mediated drug delivery lowers intraocular pressure. Transl Vis Sci Technol. 2015;4(1):1. doi:10.1167/tvst.4.6.4.
   PubMed Web of Science ®Google Scholar